login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CLEARMIND MEDICINE INC (CMND) Stock News
USA
-
Nasdaq
- NASDAQ:CMND -
CA1850534027
-
Common Stock
0.1134
USD
-0.02 (-12.5%)
Last: 12/3/2025, 1:25:53 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CMND Latest News, Press Relases and Analysis
All
Press Releases
3 hours ago - By: Chartmill
- Mentions:
AEO
AEMD
PSTG
KXIN
...
Which stocks are gapping on Wednesday?
5 hours ago - By: Chartmill
- Mentions:
CEP
ACHC
CMCT
CAPR
...
Get insights into the top gainers and losers of Wednesday's pre-market session.
a day ago - By: Chartmill
- Mentions:
PLUG
INTC
NVDA
BYND
...
Curious about the most active stocks on Tuesday?
a day ago - By: Clearmind Medicine Inc.
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder
a day ago - By: Clearmind Medicine Inc.
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder
2 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial
2 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial
8 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
8 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
9 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review
9 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review
13 days ago - By: SciSparc Ltd
- Mentions:
SPRC
NTLX.CA
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
13 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site
13 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site
15 days ago - By: Chartmill
- Mentions:
PLUG
JACK
CANF
JAGX
...
Tuesday's after hours session: top gainers and losers
15 days ago - By: Chartmill
- Mentions:
SRDX
GLMD
KXIN
APLT
...
On Tuesday, there are stocks with unusual volume. Let's take a look.
15 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
15 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
16 days ago - By: Chartmill
- Mentions:
SRDX
CMCT
ASRT
OTLK
...
On Monday, there are stocks with unusual volume. Let's take a look.
16 days ago - By: Clearmind Medicine Inc.
- Mentions:
NTLX.CA
SPRC
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
16 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
19 days ago - By: Benzinga
- Mentions:
PTN
ZYXI
AVXL
CDTX
...
12 Health Care Stocks Moving In Friday's Intraday Session
20 days ago - By: Chartmill
- Mentions:
PLUG
NVDA
OPEN
RUBI
...
Thursday's session: most active stocks
20 days ago - By: Benzinga
Clearmind Medicine (CMND) Stock Soars Thursday: What's Going On?
20 days ago - By: Chartmill
- Mentions:
RUBI
SLRX
FTCI
SWAG
...
The trading volume of these stocks is deviating from the norm in today's session.
20 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
20 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
21 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment
21 days ago - By: Clearmind Medicine Inc.
Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment
Please enable JavaScript to continue using this application.